•
MA
MAIA
MAIA Biotechnology, Inc.
yahooPHARMACEUTICAL PREPARATIONS
--
Price Chart
Market Cap
86.66M
Volume
1.33M
52W High
$2.74
52W Low
$0.87
Open
$0.00
Prev Close
$2.20
Day Range
0.00 - 0.00
About MAIA Biotechnology, Inc.
MAIA Biotechnology Inc is a clinical-stage biopharmaceutical company developing targeted immunotherapies for cancer. THIO (6-thio-dG or 6-thio-2 '-deoxyguanosine), its lead asset, is an investigational dual mechanism of action drug candidate incorporating telomere targeting and immunogenicity. Patients with advanced NSCLC will be treated first with THIO followed a few days later by the immune checkpoint inhibitor Libtayo (cemiplimab), manufactured and commercialized by Regeneron.
Latest News
MAIA Takes Aim at a $50B Immunotherapy Market with Breakthrough Telomere-Targeting Approach
GlobeNewswire Inc.•Dec 10
MAIA Biotechnology's Lung Cancer Drug Shows Promising Long-Term Benefits In Advanced Patients - Benzinga
Benzinga•Jul 23
MAIA Biotechnology Appoints Leading Immuno-Oncology Scientist Dr. Remus Vezan as Scientific Advisor
GlobeNewswire Inc.•Feb 27
MAIA Biotechnology Completes Enrollment in THIO-101 Phase 2 Clinical Trial for Non-Small Cell Lung Cancer
GlobeNewswire Inc.•Feb 22
MAIA Soars 20% on Interim Results From Lung Cancer Study
Zacks Investment Research•Jan 18
Why Wipro Shares Are Trading Higher By Over 16%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Benzinga•Jan 12
Why VCI Global Shares Are Trading Lower By Around 30%; Here Are 20 Stocks Moving Premarket
Benzinga•Jan 12
Bears are Losing Control Over MAIA Biotechnology, Inc. (MAIA), Here's Why It's a 'Buy' Now
Zacks Investment Research•Dec 1